1. Home
  2. PIII vs LSTA Comparison

PIII vs LSTA Comparison

Compare PIII & LSTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PIII
  • LSTA
  • Stock Information
  • Founded
  • PIII 2015
  • LSTA 1980
  • Country
  • PIII United States
  • LSTA United States
  • Employees
  • PIII N/A
  • LSTA N/A
  • Industry
  • PIII Medical/Nursing Services
  • LSTA Misc Health and Biotechnology Services
  • Sector
  • PIII Health Care
  • LSTA Health Care
  • Exchange
  • PIII Nasdaq
  • LSTA Nasdaq
  • Market Cap
  • PIII 37.5M
  • LSTA 31.2M
  • IPO Year
  • PIII N/A
  • LSTA N/A
  • Fundamental
  • Price
  • PIII $0.23
  • LSTA $2.51
  • Analyst Decision
  • PIII Buy
  • LSTA Strong Buy
  • Analyst Count
  • PIII 3
  • LSTA 1
  • Target Price
  • PIII $2.38
  • LSTA $15.00
  • AVG Volume (30 Days)
  • PIII 1.2M
  • LSTA 58.9K
  • Earning Date
  • PIII 03-27-2025
  • LSTA 02-27-2025
  • Dividend Yield
  • PIII N/A
  • LSTA N/A
  • EPS Growth
  • PIII N/A
  • LSTA N/A
  • EPS
  • PIII N/A
  • LSTA N/A
  • Revenue
  • PIII $1,476,630,000.00
  • LSTA N/A
  • Revenue This Year
  • PIII $21.45
  • LSTA N/A
  • Revenue Next Year
  • PIII N/A
  • LSTA N/A
  • P/E Ratio
  • PIII N/A
  • LSTA N/A
  • Revenue Growth
  • PIII 25.38
  • LSTA N/A
  • 52 Week Low
  • PIII $0.17
  • LSTA $2.19
  • 52 Week High
  • PIII $1.20
  • LSTA $4.20
  • Technical
  • Relative Strength Index (RSI)
  • PIII 60.20
  • LSTA 40.33
  • Support Level
  • PIII $0.19
  • LSTA $2.51
  • Resistance Level
  • PIII $0.25
  • LSTA $2.66
  • Average True Range (ATR)
  • PIII 0.02
  • LSTA 0.19
  • MACD
  • PIII 0.01
  • LSTA -0.01
  • Stochastic Oscillator
  • PIII 75.64
  • LSTA 17.50

About PIII P3 Health Partners Inc.

P3 Health Partners Inc is a patient-centered and physician-led population health management company. P3's model aggregates and supports the community's existing healthcare resources to build a network of community providers working together to deliver coordinated and integrated care to patients with a shared commitment to improving patient outcomes, lowering cost, and delivering experience for all.

About LSTA Lisata Therapeutics Inc.

Lisata Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to the discovery, development, and commercialization of innovative therapies for the treatment of advanced solid tumors and other major diseases. Its product candidate, LSTA1, is designed to activate a novel uptake pathway that allows co-administered or tethered (i.e., molecularly bound) anti-cancer drugs to target and penetrate solid tumors more effectively.

Share on Social Networks: